abstract |
A method for preventing loss of bone mass or bone mineral content in a human being suffering from secondary hyperparathyroidism by administering a sufficient amount of 1 alpha -OH vitamin D2, 1 alpha ,24(S)-(OH)2 vitamin D2, 1 alpha -OH vitamin D4 or 1 alpha ,24(R)-(OH)2 vitamin D4. |